First Vyluma product tackles pediatric myopia

Video

Dive deep into Vyluma’s investigational atropine therapy. Navneet Puri, PhD, the company’s founder, chairman, and CEO, explains details of the clinical trials.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Karl Stonecipher ASCRS 2025
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Eva Kim, MD, shares visual outcomes of EVO implantable collamer lens in patients with low to moderate myopia.
Dr Ashley Wallace Tucker speaks on the Myopia Management Navigator.
Paul Karpecki, OD, FAAO
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
Related Content
European Commission approves low-dose atropine eye drop Ryjunea, Santen announces - Image credit: ©artjazz—stock.adobe.com

European Commission approves low-dose atropine eye drop Ryjunea, Santen announces

Hattie Hayes
June 5th 2025
Article
You and Eye by Optometry Times with host Miriam Korik, OD

You and Eye: Myopia cannot be viewed as a specialty in today's practice setting

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
October 18th 2024
Podcast
iVeena submits IND to FDA for a phase 2 clinical trial for pediatric myopia ©OHishi_Foto—stock.adobe.com

iVeena submits IND to FDA for a phase 2 clinical trial for pediatric myopia

Emily Kaiser Maharjan, Assistant Managing Editor
June 4th 2025
Article
You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO

You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
October 9th 2024
Podcast
New data on DOT lenses show strong global performance in myopia control - Image credit: ©MIA Studio—stock.adobe.com

Clinical trial Q&A: New data on DOT lenses show strong global performance in myopia control

Emily Kaiser Maharjan, Assistant Managing Editor;Debbie Laughton, BSc, PhD
May 27th 2025
Article
Child applying contact lens to eye Image credit: AdobeStock/zulfiska

New study supports retention of myopia control in CooperVision's MiSight 1 day contact lenses

Jordana Joy, Associate Editor
May 6th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.